AR036583A1 - Compuestos de tetrahidroquinolinas, un procedimiento para su preparacion, medicamentos y el uso de dichos compuestos para la preparacion de medicamentos - Google Patents

Compuestos de tetrahidroquinolinas, un procedimiento para su preparacion, medicamentos y el uso de dichos compuestos para la preparacion de medicamentos

Info

Publication number
AR036583A1
AR036583A1 ARP020103608A ARP020103608A AR036583A1 AR 036583 A1 AR036583 A1 AR 036583A1 AR P020103608 A ARP020103608 A AR P020103608A AR P020103608 A ARP020103608 A AR P020103608A AR 036583 A1 AR036583 A1 AR 036583A1
Authority
AR
Argentina
Prior art keywords
preparation
compounds
medications
medicines
procedure
Prior art date
Application number
ARP020103608A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR036583A1 publication Critical patent/AR036583A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
ARP020103608A 2001-10-01 2002-09-25 Compuestos de tetrahidroquinolinas, un procedimiento para su preparacion, medicamentos y el uso de dichos compuestos para la preparacion de medicamentos AR036583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10148436A DE10148436A1 (de) 2001-10-01 2001-10-01 Tetrahydrochinoline

Publications (1)

Publication Number Publication Date
AR036583A1 true AR036583A1 (es) 2004-09-15

Family

ID=7701007

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103608A AR036583A1 (es) 2001-10-01 2002-09-25 Compuestos de tetrahidroquinolinas, un procedimiento para su preparacion, medicamentos y el uso de dichos compuestos para la preparacion de medicamentos

Country Status (12)

Country Link
US (1) US20050043341A1 (https=)
EP (1) EP1434581A1 (https=)
JP (1) JP2005508341A (https=)
AR (1) AR036583A1 (https=)
CA (1) CA2462030A1 (https=)
DE (1) DE10148436A1 (https=)
DO (1) DOP2002000457A (https=)
GT (1) GT200200195A (https=)
HN (1) HN2002000278A (https=)
PE (1) PE20030604A1 (https=)
UY (1) UY27458A1 (https=)
WO (1) WO2003028727A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003357A (es) * 2003-09-26 2006-06-08 Japan Tobacco Inc Metodo para inhibir la produccion de lipoproteina remanente.
DE602004023100D1 (de) 2003-10-08 2009-10-22 Lilly Co Eli Verbindungen und verfahren zur behandlung von dyslipidemie
JP2007530550A (ja) 2004-03-26 2007-11-01 イーライ リリー アンド カンパニー 異脂肪血症を治療するための化合物および方法
ES2384980T3 (es) * 2004-12-18 2012-07-16 Bayer Pharma Aktiengesellschaft Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos
BRPI0519566A2 (pt) * 2004-12-18 2009-01-27 Bayer Healthcare Ag derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp
DE102006012548A1 (de) 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
CN101096363B (zh) * 2006-06-27 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
US20080145498A1 (en) * 2006-12-14 2008-06-19 Kraft Foods Holdings, Inc. Texture and shape control process for acidified food products
BRPI0909105A2 (pt) * 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
UY33229A (es) * 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
CA2804924C (en) 2010-07-09 2016-06-28 Daiichi Sankyo Company, Limited Substituted pyridine compound
EP2760868B1 (en) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
TWI570118B (zh) 2012-01-06 2017-02-11 第一三共股份有限公司 經取代之吡啶化合物的酸加成鹽
JP6742316B2 (ja) 2014-09-09 2020-08-19 ベーリンガー インゲルハイム インターナショナル トレイディング (シャンハイ) カンパニー リミテッド スピロ[2.5]オクタン−5,7−ジオンおよびスピロ[3.5]ノナン−6,8−ジオンの調製のための新規なプロセス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
MA24643A1 (fr) * 1997-09-18 1999-04-01 Bayer Ag Tetrahydro-naphtalenes substitues et composes analogues
DE19741051A1 (de) * 1997-09-18 1999-03-25 Bayer Ag Hetero-Tetrahydrochinoline
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline

Also Published As

Publication number Publication date
GT200200195A (es) 2003-08-22
US20050043341A1 (en) 2005-02-24
WO2003028727A9 (de) 2003-11-13
DE10148436A1 (de) 2003-04-17
JP2005508341A (ja) 2005-03-31
WO2003028727A1 (de) 2003-04-10
CA2462030A1 (en) 2003-04-10
DOP2002000457A (es) 2003-04-15
UY27458A1 (es) 2003-04-30
PE20030604A1 (es) 2003-09-07
HN2002000278A (es) 2002-12-20
EP1434581A1 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
AR036583A1 (es) Compuestos de tetrahidroquinolinas, un procedimiento para su preparacion, medicamentos y el uso de dichos compuestos para la preparacion de medicamentos
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
PA8547701A1 (es) Nucleosidos 4 substituidos.
ECSP088405A (es) Nuevos derivados de pirimidina y su uso en terapia, así como el uso de derivados de pirimidina en la fabricación de un medicamento para la prevención y/o tratamiento de la enfermedad de alzheimer
BR0312513A (pt) Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
UY28369A1 (es) Agentes terapéuticos
CU23105A3 (es) DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS
UY26863A1 (es) Derivados de la piperazina
AR016431A1 (es) Derivados de piperidina, un proceso para su preparacion, medicamentos que los comprenden y el uso de dichos derivados para la manufactura de un medicamento
AR012653A1 (es) UNA COMPOSICIoN NUTRICIONAL QUE COMPRENDE EXTRACTO DE PLANTA PARA EL TRATAMIENTO DE RESORCIoN oSEA INCREMENTADA Y EL USO LA MISMA PARA LA PREPARACIoN DE UN MEDICAMENTO.
ECSP034571A (es) Nuevas composiciones de medicamentos a base de sales de tiotropio y sales del salmeterol
UY30398A1 (es) " uso de antagonistas de cgrp (a), sus enantinmeros, diasternmeros, mezclas y sales farmaccuticamente aceptables para preparar medicamentos, y composiciones que los contienen"
ECSP034518A (es) Nuevos retinoides para el tratamiento de enfisema
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
BR0311189A (pt) Composições farmacêuticas contendo polimorfo a de flibanserin
UY28408A1 (es) Agentes terapeuticos
BR0208688A (pt) Lipìdeo diminuindo bifenil carboxamidas
BR0313377A (pt) Bifenilcarnboxamidas substituìdas por n-aril piperidina como inibidores de secreção de apolipoproteìna b
AR041865A1 (es) Derivados terapeuticos de prolina y su uso en el tratamiento de epilepsia y dolor
AR029637A1 (es) Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos

Legal Events

Date Code Title Description
FB Suspension of granting procedure